Prevention of early-onset group B streptococcal disease: another look at single-dose penicillin at birth

J D Siegel1, N B Cushion

  • 1Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, USA.

Insights

Single-dose penicillin at birth significantly reduced early-onset group B streptococcal (GBS) invasive disease in newborns. This safe and effective intervention demonstrates the value of universal prophylaxis for GBS prevention.

Area of Science:

  • Neonatal Infectious Diseases
  • Pediatric Infectious Diseases
  • Antibiotic Prophylaxis

Background:

  • Group B Streptococcus (GBS) remains a significant cause of neonatal invasive disease.
  • Early-onset GBS disease presents a critical public health challenge, particularly in inner-city populations.
  • Effective preventive strategies are essential to reduce neonatal morbidity and mortality associated with GBS.

Purpose of the Study:

  • To evaluate the impact of a single prophylactic dose of penicillin administered at birth on the incidence of early-onset GBS invasive disease.
  • To assess the efficacy of penicillin prophylaxis in a large, diverse inner-city population over an extended period.
  • To determine the safety and effectiveness of universal penicillin administration for GBS prevention in newborns.

Main Methods:

  • Retrospective analysis of laboratory-based surveillance data for GBS disease from 1972-1994.
  • Inclusion of 259,049 live births from Parkland Memorial Hospital, Dallas, Texas.
  • Comparison of early-onset GBS disease rates across five distinct observation periods with varying penicillin prophylaxis strategies.

Main Results:

  • Penicillin prophylaxis groups demonstrated significantly lower rates of early-onset GBS disease (0.25 and 0.63 per 1,000) compared to untreated groups (1.59, 1.19, and 1.95 per 1,000).
  • Penicillin prophylaxis did not affect the incidence of late-onset GBS disease.
  • No increase in penicillin-resistant pathogens or associated mortality was observed in infants receiving penicillin.

Conclusions:

  • Universal administration of a single dose of penicillin at birth is a safe and highly effective method for preventing early-onset GBS disease.
  • This intervention offers a significant public health benefit by reducing neonatal GBS infections.
  • The findings support the widespread implementation of penicillin prophylaxis for GBS prevention in newborns.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.